There is no clear evidence of an increased risk for myocardial infarction, stroke, or other cardiovascular events associated with the use of entacapone for the treatment of Parkinson's disease (PD), a ...

Company states the realisation of generic competition is still neither certain nor imminent Orion Corporation has been informed that Sun Pharma Global, Inc. has filed an Abbreviated New Drug ...

CHICAGO (Reuters) - Drugs used to treat Parkinson's disease show promise as a new way to stem the rise of drug-resistant forms of tuberculosis, U.S. researchers said on Thursday. They said computer ...

Mylan Inc. said Thursday that it had reached an agreement to settle patent litigation over the generic version of Orion Corp.'s Comtan. Mylan Inc. said Thursday that it had reached an agreement to ...

In a BSE filing, Ajanta Pharma said it has recieved "final approval for Entacapone tablets from US FDA. It is a bioequivalent generic version of Comtan tablets". NEW DELHI: Ajanta Pharma has received ...

Sun Pharmaceutical Industries Ltd and its affiliates have settled a lawsuit filed by Orion in the United States against Sun Pharma over its abbreviated new drug applications (ANDAs) for generic ...

Wockhardt has got USFDA nod for generic version of Comtan, reports CNBC-TV18. The share touched a 52-week high of Rs 1,325. At 09:24 hrs the share was quoting at Rs 1,318.00, up Rs 19.35, or 1.49%.

* Drugs could be used to fight dangerous forms of TB * Compounds already proven in humans By Julie Steenhuysen CHICAGO, July 2 (Reuters) - Drugs used to treat Parkinson's disease show promise as a new ...